Catalent | CTLT - Assets


Catalent reported $10.51B in Assets for its fiscal quarter ending in June of 2025.



Assets Change Date
Agilent USD 12.81B 86M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Bruker USD 6.24B 193.5M Dec/2025
Centene USD 76.75B 5.34B Dec/2025
Charles River Laboratories USD 7.14B 378.39M Dec/2025
Cigna USD 157.92B 0 Dec/2025
Danaher USD 83.46B 3.57B Dec/2025
Dentsply International USD 5.43B 224M Dec/2025
Elevance Health USD 121.49B 1.26B Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Glaxosmithkline GBP 82.34B 102.25M Dec/2025
Hologic USD 9.18B 165.8M Dec/2025
Humana USD 48.91B 810M Dec/2025
Illumina USD 6.64B 467M Dec/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Laboratory Of America USD 18.39B 131.1M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
McKesson USD 84.19B 30M Dec/2025
Merck EUR 51.53B 600M Dec/2025
Merck USD 129.55B 12.02B Sep/2025
Mettler Toledo International USD 3.71B 191.18M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
Quest Diagnostics USD 16.23B 28M Dec/2025
Repligen USD 2.95B 25.99M Dec/2025
Revvity USD 12.17B 29.46M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Supernus Pharmaceuticals USD 1.45B 32.89M Dec/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
UnitedHealth USD 309.58B 5.69B Dec/2025
Veradigm USD 1.5B 185.94M Dec/2022
Waters USD 5.08B 221.41M Dec/2025
West Pharmaceutical Services USD 4.27B 164.2M Dec/2025